CN Patent

CN101918425B — 核苷氨基磷酸酯前药

Assigned to Gilead Sciences Inc · Expires 2023-05-02 · 3y expired

What this patent protects

本文公开了用于治疗哺乳动物病毒性感染的核苷衍生物的氨基磷酸酯前药，该氨基磷酸酯前药是由以下结构表示的化合物、它的立体异构体、其盐(酸或碱加成盐)、水合物、溶剂合物或结晶形式：还公开了各自利用式(I)所示化合物的治疗方法、用途以及制备方法。

USPTO Abstract

本文公开了用于治疗哺乳动物病毒性感染的核苷衍生物的氨基磷酸酯前药，该氨基磷酸酯前药是由以下结构表示的化合物、它的立体异构体、其盐(酸或碱加成盐)、水合物、溶剂合物或结晶形式：还公开了各自利用式(I)所示化合物的治疗方法、用途以及制备方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN101918425B
Jurisdiction: CN
Classification: —
Expires: 2023-05-02
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.